Conference Program

Conference Program

15:00-15:10

Welcome Address

Plenary Hall
Plenary Hall

Keynote lecture: CAR T CELLS – A ROAD TRIP TO TUMOR ELIMINATION
Stan Riddell,
Fred Hutchinson Cancer Research Center, USA

CAR T CELL THERAPIES IN LYMPHOMA: CURRENT STATUS OF IND-APPROVED STUDIES IN CHINA
Yuqin Song,
Peking University Cancer Hospital, China

MULTIPLE GENOME EDITING IN T CELLS FOR CANCER IMMUNOTHERAPY
Chiara Bonini,
San Raffaele University, Italy

TBC
Michal Besser,
Tel Aviv University, Israel

TBC
Jennifer Brogdon,
Novartis Institutes for Biomed.Research, Inc., USA

Discussion

Plenary Hall

GENETIC ENGINEERING OF REGULATORY AND EFFECTOR T CELLS
Hans Stauss,
University College London, UK

L1CAM-SPECIFIC CAR T CELL THERAPY FOR CHILDHOOD NEUROBLASTOMA
Annette Künkele,
Charité,Germany

ENHANCEMENT OF CAR T CELL FUNCTION WITH A CONSTITUTIVELY ACTIVE IL-7 RECEPTOR
Bilal Omer,
Baylor College of Medicine, USA

TBC

Discussion

08:30 – 09:50

CAR/TCR Design

Plenary Hall

TCR GENE THERAPY TARGETING ‘PUBLIC’ NEOANTIGENS RESULTING FROM COMMON DRIVER ONCOGENES
Chris Klebanoff,
Memorial Sloan Kettering Cancer Center, USA

NEOANTIGEN-SPECIFIC T-CELL RECEPTORS AS PERSONALIZED TOOLS IN THE TREATMENT OF CANCER
Angela Krackhard,
Klinikum rechts der Isar, Technical University of Munich, Germany

PRIMARY STRUCTURE INFLUENCE ON THE EXPRESSION AND FUNCTION OF TCRS, CARS AND CSRS FOR T-CELL IMMUNOTHERAPY
Cyrille Cohen,
Bar-Ilan University, Israel

TBC

Discussion

Plenary Hall

ENGINEERING INKT CELLS FOR DUAL TARGETING OF CANCER AND SUPPRESSIVE MYELOID CELLS
Paolo Dellabona,
San Raffaele Scientific Institute, Italy

THERAPEUTIC POTENTIAL OF INVARIANT NATURAL KILLER T CELLS MODIFIED WITH CD38 OR BCMA CHIMERIC ANTIGEN RECEPTORS FOR MULTIPLE MYELOMA
Tuna Mutis,
Amsterdam University Medical Center, Netherlands

GAMMA DELTA CAR-T APPROACHES TO REFINE SPECIFICITY AND SENSITIVITY
John Anderson,
University College London, UK

Discussion

12:05 – 13:35

Universal Donor Cells

Plenary Hall

Keynote lecture: FRATRICIDE AS AN ENABLER OF UNIVERSAL T CELL THERAPY
“WAS MICH NICHT UMBRINGT, MACHT MICH STÄRKER``
Malcolm Brenner,
Houston Methodist Hospital, USA

INCREASING THE SAFETY OF CAR TECHNOLOGY: GATED TARGETING WITH MODULAR CARS
Michael Bachmann,
University Hospital Carl Gustav Carus Dresden, Germany

CRISPR CUT AND UNCUT CAR T CELLS FOR LEUKAEMIA
Waseem Qasim,
University College London,UK

TBC

Discussion

Plenary Hall

Keynote lecture: TBC
Michel Sadelain,
Memorial Sloan Kettering Cancer Center, USA

ADOPTIVE TRANSFER OF VIRUS-SPECIFIC T CELLS IN THE IMMUNOCOMPROMISED HOST
Tobias Feuchtinger,
Ludwig-Maximilians-University, Germany

SIGNALING AND CYTOKINE ENGINEERING OF CAR-T CELLS
Gianpietro Dotti,
University of North Carolina Lineberger Comprehensive Cancer Center, USA

UPDATES IN CAR T ENGINEERING
Carl June,
Parker Institute Cancer Immunotherapy; University of Pennsylvania USA

TBA

Discussion

Plenary Hall

ORTHOTOPIC TCR REPLACEMENT ENABLES GENERATION OF PREDICTABLE ANTIGEN-SPECIFIC T CELL PRODUCTS
Dirk Busch,
Technical University of Munich, Germany

T CELL THERAPY FOR VIRUSES
Ann Leen,
Baylor College of Medicine, USA

IN VIVO ENGINEERED B CELLS RETAIN MEMORY AND SECRETE HIGH TITERS OF ANTI-HIV ANTIBODIES IN MICE
Adi Barzel,
Tel-Aviv University, Israel

TBC

Discussion

Plenary Hall

PIGGYBAC TRANSPOSON-MEDIATED CAR-T CELLS: A PROMISING AND REALISTIC APPROACH FOR CLINICAL APPLICATION
Shigeki Yagyu,
Kyoto Prefectural University of Medicine, Japan

NOVEL TARGETS AND TECHNOLOGIES FOR CAR T-CELL THERAPY
Michael Hudecek,
Hospital of the University of Würzburg, Germany

TBC

Discussion

Plenary Hall

Keynote lecture: T-CELL BASED GENE THERAPY FOR THE HYPERIGM IMMUNODEFICIENCY EXPLOITING GENE EDITING
Luigi Naldini,
San Raffaele Telethon Institute for Gene Therapy, Italy

TANDEM CD19-CD20 CAR T TREATMENT IN R/RNHL
Weidong Han,
Chinese PLA General Hospital, China

CARS AND TRUCKS AND THE NEXT GENERATION CAR T CELLS
Hinrich Abken,
Regensburg Center for Interventional Immunotherpay, Germany

Plenary Hall

Panelists: TBA

12:25 - 12:30

Closing Address

Plenary Hall